Target Name: RNF138P1
NCBI ID: G379013
Review Report on RNF138P1 Target / Biomarker Content of Review Report on RNF138P1 Target / Biomarker
RNF138P1
Other Name(s): Ring finger protein 138 pseudogene 1 | ring finger protein 138 pseudogene 1

Ring finger protein 138 (RF138P1): A Potential Drug Target and Biomarker

Ring finger protein 138 (RF138P1) is a gene that encodes a protein located at the X chromosome's long arm, specifically at position 138. It is one of the highly conserved genes in the human genome, with similar proteins found in many species, including humans, mouse, and worm. The RF138P1 gene has been implicated in various cellular processes, including cell adhesion, migration, and regulation of cell growth.

Recent studies have identified RF138P1 as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This article will review the current understanding of RF138P1 and its potential as a drug target and biomarker.

Potential Drug Target

RF138P1 has been identified as a potential drug target due to its involvement in various cellular processes that are crucial for disease development. Several studies have shown that RF138P1 is involved in several important cellular processes, including:

1. Cell Adhesion: RF138P1 is a member of the cadherin family, which are known to play a critical role in cell-cell adhesion. The cadherins help maintain the integrity of tissues and are involved in various physiological processes, including embryonic development, tissue repair, and cancer progression.

2. Cell Migration: RF138P1 is involved in the regulation of cell migration, which is a critical process for the development and progression of many diseases, including cancer. The ability of cells to migrate through the body is critical for their survival and the formation of tumors.

3. Cell Growth: RF138P1 is involved in regulating cell growth, which is a crucial process for the development and maintenance of tissues. Disruptions in cell growth can lead to various diseases, including cancer.

4.Apoptosis: RF138P1 is involved in regulating apoptosis, which is a natural process that helps remove damaged or dysfunctional cells from the body.

Potential Biomarker

RF138P1 has also been identified as a potential biomarker for various diseases due to its expression in various tissues and its potential to be targeted by small molecules. The expression of RF138P1 has been shown in various tissues, including brain, heart, and pancreas, which suggests its potential as a biomarker for these diseases.

Additionally, several studies have shown that small molecules can interact with RF138P1 and modulate its expression. This suggests that RF138P1 may be a drug target and that its expression may be a biomarker for various diseases.

Conclusion

In conclusion, RF138P1 is a gene that has been implicated in various cellular processes that are crucial for disease development. Its potential as a drug target and biomarker makes it an attractive target for research into various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further studies are needed to fully understand the role of RF138P1 in disease development and its potential as a drug and biomarker.

Protein Name: Ring Finger Protein 138 Pseudogene 1

The "RNF138P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNF138P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RNF139 | RNF139-DT | RNF14 | RNF141 | RNF144A | RNF144B | RNF145 | RNF146 | RNF148 | RNF149 | RNF150 | RNF151 | RNF152 | RNF157 | RNF157-AS1 | RNF165 | RNF166 | RNF167 | RNF168 | RNF169 | RNF17 | RNF170 | RNF175 | RNF180 | RNF181 | RNF182 | RNF183 | RNF185 | RNF186 | RNF187 | RNF19A | RNF19B | RNF2 | RNF20 | RNF207 | RNF208 | RNF212 | RNF212B | RNF213 | RNF213-AS1 | RNF214 | RNF215 | RNF216 | RNF216-IT1 | RNF216P1 | RNF217 | RNF217-AS1 | RNF220 | RNF222 | RNF224 | RNF225 | RNF227 | RNF24 | RNF25 | RNF26 | RNF31 | RNF32 | RNF32-DT | RNF34 | RNF38 | RNF39 | RNF4 | RNF40 | RNF41 | RNF43 | RNF44 | RNF5 | RNF5P1 | RNF6 | RNF7 | RNF7P1 | RNF8 | RNFT1 | RNFT2 | RNGTT | RNH1 | RNLS | RNMT | RNPC3 | RNPC3-DT | RNPEP | RNPEPL1 | RNPS1 | RNPS1P1 | RNR1 | RNR2 | RNU1-1 | RNU1-100P | RNU1-108P | RNU1-11P | RNU1-134P | RNU1-18P | RNU1-3 | RNU1-31P | RNU1-32P | RNU1-36P | RNU1-38P | RNU1-4 | RNU1-42P | RNU1-55P